The daily SAH checklist, written for you

Nimodipine dose and stop date, euvolemia (no prophylactic hypervolemia), daily transcranial Dopplers in the window, the response to clinical delayed cerebral ischemia (induced hypertension and endovascular rescue), fever control, glucose, VTE prophylaxis timing relative to securing the aneurysm, and the family update — each is a line the builder writes from a toggle. The result reads like the note a senior fellow would write on rounds, in the order the ICU team actually reviews.

Grade is not destiny

The builder carries the guideline reminder that poor-grade patients can recover and that early withdrawal on the basis of grade alone is discouraged. It also handles the angio-negative case correctly: a perimesencephalic pattern carries an excellent prognosis but still needs the repeat vascular study at about a week.

Where this fits with the other builders

ICH with intraventricular extension, post-thrombectomy ICU care, status epilepticus, and myasthenic crisis have their own builders in the residents' workspace; the engine is shared, so preferences and saved phrases carry across.

Frequently asked questions

Does the builder change the plan for an unsecured aneurysm?

Yes. It writes the securing-first line (coil or clip, ideally within 24 hours), the pre-securing SBP target under 160, no antithrombotics, and no routine antifibrinolytic; once you mark the aneurysm coiled or clipped, the blood-pressure section liberalizes and the VTE prophylaxis line advances.

What does the builder do with a low sodium?

It writes the SAH-specific answer: do not fluid-restrict; use salt tablets or hypertonic saline; assess volume status to separate cerebral salt wasting from SIADH; and consider fludrocortisone. Very low values are flagged.

Is this a substitute for my unit's SAH protocol?

No. It is an educational documentation aid that applies published guideline logic to what you enter. Institutional targets, agents, and monitoring schedules come first, and every line is editable.

References

  1. Hoh BL, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage. Stroke. 2023;54:e314–e370.
  2. Molyneux AJ, et al. International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2002;360:1267–1274.
  3. Pickard JD, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage (BRANT). BMJ. 1989;298:636–642.
  4. Post R, et al. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA). Lancet. 2021;397:112–118.